APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Botanical and Herbal Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Botanical and Herbal Drug Market Analysis and Forecast 2026-2032

Report ID 17397205022 January 2026193 pages

Choose your research edition.

Industry ResearchBotanical and Herbal Drug Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Botanical and Herbal Drug Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Botanical and Herbal Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Botanical and Herbal Drug Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Botanical and Herbal Drug Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Botanical and Herbal Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Botanical and Herbal Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Botanical and Herbal Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Botanical and Herbal Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Botanical and Herbal Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Botanical and Herbal Drug include China TCM, Yunnan Baiyao, Tong Ren Tang, Kwangdong, Guangzhou Baiyunshan Pharmaceutical, Weleda, Tsumura, Tasly Holding Group and Taiji, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Botanical and Herbal Drug, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Botanical and Herbal Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Botanical and Herbal Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Botanical and Herbal Drug revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Botanical and Herbal Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Botanical and Herbal Drug revenue, projected growth trends, production technology, application and end-user industry.

Botanical and Herbal Drug Segment by Company

China TCM

Yunnan Baiyao

Tong Ren Tang

Kwangdong

Guangzhou Baiyunshan Pharmaceutical

Weleda

Tsumura

Tasly Holding Group

Taiji

Schwabe

Jumpcan Pharmaceutical

Huarun 999

GW Pharmaceuticals

Buchang Pharmaceuticals

Bionorica Se

Botanical and Herbal Drug Segment by Type

Prescription Drug

OTC

Botanical and Herbal Drug Segment by Application

Respiratory System

Cardiovascular

Tumor

Other

Botanical and Herbal Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Botanical and Herbal Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Botanical and Herbal Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Botanical and Herbal Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Botanical and Herbal Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Botanical and Herbal Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Botanical and Herbal Drug revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Botanical and Herbal Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Prescription Drug Major Player Table 3. OTC Major Player Table 4. Global Botanical and Herbal Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Respiratory System Major Player Table 6. Cardiovascular Major Player Table 7. Tumor Major Player Table 8. Other Major Player Table 9. Botanical and Herbal Drug Industry Trends Table 10. Botanical and Herbal Drug Industry Drivers Table 11. Botanical and Herbal Drug Industry Opportunities and Challenges Table 12. Botanical and Herbal Drug Industry Restraints Table 13. Global Botanical and Herbal Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Botanical and Herbal Drug Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Botanical and Herbal Drug Market Share by Region (2021-2026) Table 16. Global Botanical and Herbal Drug Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Botanical and Herbal Drug Market Share by Region (2027-2032) Table 18. Global Botanical and Herbal Drug Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Botanical and Herbal Drug Revenue Market Share by Players (2021-2026) Table 20. Global Botanical and Herbal Drug Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Botanical and Herbal Drug Key Players Headquarters & Area Served Table 22. Global Botanical and Herbal Drug Players, Product Type & Application Table 23. Global Botanical and Herbal Drug Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Botanical and Herbal Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Botanical and Herbal Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Botanical and Herbal Drug Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Botanical and Herbal Drug Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Botanical and Herbal Drug Revenue Market Share by Type (2021-2026) Table 30. Global Botanical and Herbal Drug Revenue Market Share by Type (2027-2032) Table 31. Global Botanical and Herbal Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Botanical and Herbal Drug Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Botanical and Herbal Drug Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Botanical and Herbal Drug Revenue Market Share by Application (2021-2026) Table 35. Global Botanical and Herbal Drug Revenue Market Share by Application (2027-2032) Table 36. China TCM Company Information Table 37. China TCM Business Overview Table 38. China TCM Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. China TCM Botanical and Herbal Drug Product Portfolio Table 40. China TCM Recent Development Table 41. Yunnan Baiyao Company Information Table 42. Yunnan Baiyao Business Overview Table 43. Yunnan Baiyao Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Yunnan Baiyao Botanical and Herbal Drug Product Portfolio Table 45. Yunnan Baiyao Recent Development Table 46. Tong Ren Tang Company Information Table 47. Tong Ren Tang Business Overview Table 48. Tong Ren Tang Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Tong Ren Tang Botanical and Herbal Drug Product Portfolio Table 50. Tong Ren Tang Recent Development Table 51. Kwangdong Company Information Table 52. Kwangdong Business Overview Table 53. Kwangdong Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Kwangdong Botanical and Herbal Drug Product Portfolio Table 55. Kwangdong Recent Development Table 56. Guangzhou Baiyunshan Pharmaceutical Company Information Table 57. Guangzhou Baiyunshan Pharmaceutical Business Overview Table 58. Guangzhou Baiyunshan Pharmaceutical Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Guangzhou Baiyunshan Pharmaceutical Botanical and Herbal Drug Product Portfolio Table 60. Guangzhou Baiyunshan Pharmaceutical Recent Development Table 61. Weleda Company Information Table 62. Weleda Business Overview Table 63. Weleda Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Weleda Botanical and Herbal Drug Product Portfolio Table 65. Weleda Recent Development Table 66. Tsumura Company Information Table 67. Tsumura Business Overview Table 68. Tsumura Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Tsumura Botanical and Herbal Drug Product Portfolio Table 70. Tsumura Recent Development Table 71. Tasly Holding Group Company Information Table 72. Tasly Holding Group Business Overview Table 73. Tasly Holding Group Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Tasly Holding Group Botanical and Herbal Drug Product Portfolio Table 75. Tasly Holding Group Recent Development Table 76. Taiji Company Information Table 77. Taiji Business Overview Table 78. Taiji Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Taiji Botanical and Herbal Drug Product Portfolio Table 80. Taiji Recent Development Table 81. Schwabe Company Information Table 82. Schwabe Business Overview Table 83. Schwabe Botanical and Herbal Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Schwabe Botanical and Herbal Drug Product Portfolio Table 85. Schwabe Recent Development Table 86. Jumpcan Pharmaceutical Company Information Table 87. Jumpcan Pharmaceutical Business Overview Table 88. Jumpcan Pharmaceutical Botanical and Herbal Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Jumpcan Pharmaceutical Botanical and Herbal Drug Product Portfolio Table 90. Jumpcan Pharmaceutical Recent Development Table 91. Huarun 999 Company Information Table 92. Huarun 999 Business Overview Table 93. Huarun 999 Botanical and Herbal Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Huarun 999 Botanical and Herbal Drug Product Portfolio Table 95. Huarun 999 Recent Development Table 96. GW Pharmaceuticals Company Information Table 97. GW Pharmaceuticals Business Overview Table 98. GW Pharmaceuticals Botanical and Herbal Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. GW Pharmaceuticals Botanical and Herbal Drug Product Portfolio Table 100. GW Pharmaceuticals Recent Development Table 101. Buchang Pharmaceuticals Company Information Table 102. Buchang Pharmaceuticals Business Overview Table 103. Buchang Pharmaceuticals Botanical and Herbal Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Buchang Pharmaceuticals Botanical and Herbal Drug Product Portfolio Table 105. Buchang Pharmaceuticals Recent Development Table 106. Bionorica Se Company Information Table 107. Bionorica Se Business Overview Table 108. Bionorica Se Botanical and Herbal Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Bionorica Se Botanical and Herbal Drug Product Portfolio Table 110. Bionorica Se Recent Development Table 111. North America Botanical and Herbal Drug Revenue by Type (2021-2026) & (US$ Million) Table 112. North America Botanical and Herbal Drug Revenue by Type (2027-2032) & (US$ Million) Table 113. North America Botanical and Herbal Drug Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Botanical and Herbal Drug Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Botanical and Herbal Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Botanical and Herbal Drug Revenue by Country (2021-2026) & (US$ Million) Table 117. North America Botanical and Herbal Drug Revenue by Country (US$ Million) & (2027-2032) Table 118. Europe Botanical and Herbal Drug Revenue by Type (2021-2026) & (US$ Million) Table 119. Europe Botanical and Herbal Drug Revenue by Type (2027-2032) & (US$ Million) Table 120. Europe Botanical and Herbal Drug Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe Botanical and Herbal Drug Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe Botanical and Herbal Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Botanical and Herbal Drug Revenue by Country (2021-2026) & (US$ Million) Table 124. Europe Botanical and Herbal Drug Revenue by Country (US$ Million) & (2027-2032) Table 125. China Botanical and Herbal Drug Revenue by Type (2021-2026) & (US$ Million) Table 126. China Botanical and Herbal Drug Revenue by Type (2027-2032) & (US$ Million) Table 127. China Botanical and Herbal Drug Revenue by Application (2021-2026) & (US$ Million) Table 128. China Botanical and Herbal Drug Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia Botanical and Herbal Drug Revenue by Type (2021-2026) & (US$ Million) Table 130. Asia Botanical and Herbal Drug Revenue by Type (2027-2032) & (US$ Million) Table 131. Asia Botanical and Herbal Drug Revenue by Application (2021-2026) & (US$ Million) Table 132. Asia Botanical and Herbal Drug Revenue by Application (2027-2032) & (US$ Million) Table 133. Asia Botanical and Herbal Drug Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia Botanical and Herbal Drug Revenue by Region (US$ Million) & (2021-2026) Table 135. Asia Botanical and Herbal Drug Revenue by Region (US$ Million) & (2027-2032) Table 136. SAMEA Botanical and Herbal Drug Revenue by Type (2021-2026) & (US$ Million) Table 137. SAMEA Botanical and Herbal Drug Revenue by Type (2027-2032) & (US$ Million) Table 138. SAMEA Botanical and Herbal Drug Revenue by Application (2021-2026) & (US$ Million) Table 139. SAMEA Botanical and Herbal Drug Revenue by Application (2027-2032) & (US$ Million) Table 140. SAMEA Botanical and Herbal Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. SAMEA Botanical and Herbal Drug Revenue by Country (2021-2026) & (US$ Million) Table 142. SAMEA Botanical and Herbal Drug Revenue by Country (US$ Million) & (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Botanical and Herbal Drug Image Figure 2. Global Botanical and Herbal Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Botanical and Herbal Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Prescription Drug Image Figure 5. OTC Image Figure 6. Global Botanical and Herbal Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Botanical and Herbal Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Respiratory System Image Figure 9. Cardiovascular Image Figure 10. Tumor Image Figure 11. Other Image Figure 12. Global Botanical and Herbal Drug Market Size (US$ Million) & (2021-2032) Figure 13. Global Botanical and Herbal Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Botanical and Herbal Drug Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Botanical and Herbal Drug Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Botanical and Herbal Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Botanical and Herbal Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Botanical and Herbal Drug Revenue Market Share by Type (2021-2032) Figure 20. Global Botanical and Herbal Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Botanical and Herbal Drug Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Botanical and Herbal Drug Revenue Market Share by Application (2021-2032) Figure 23. North America Botanical and Herbal Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Botanical and Herbal Drug Revenue Share by Type (2021-2032) Figure 25. North America Botanical and Herbal Drug Revenue Share by Application (2021-2032) Figure 26. North America Botanical and Herbal Drug Revenue Share by Country (2021-2032) Figure 27. United States Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Botanical and Herbal Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Botanical and Herbal Drug Revenue Share by Type (2021-2032) Figure 32. Europe Botanical and Herbal Drug Revenue Share by Application (2021-2032) Figure 33. Europe Botanical and Herbal Drug Revenue Share by Country (2021-2032) Figure 34. Germany Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Botanical and Herbal Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Botanical and Herbal Drug Revenue Share by Type (2021-2032) Figure 44. China Botanical and Herbal Drug Revenue Share by Application (2021-2032) Figure 45. Asia Botanical and Herbal Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Botanical and Herbal Drug Revenue Share by Type (2021-2032) Figure 47. Asia Botanical and Herbal Drug Revenue Share by Application (2021-2032) Figure 48. Asia Botanical and Herbal Drug Revenue Share by Region (2021-2032) Figure 49. Japan Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Botanical and Herbal Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Botanical and Herbal Drug Revenue Share by Type (2021-2032) Figure 57. SAMEA Botanical and Herbal Drug Revenue Share by Application (2021-2032) Figure 58. SAMEA Botanical and Herbal Drug Revenue Share by Country (2021-2032) Figure 59. Brazil Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Botanical and Herbal Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription Drug
  • OTC
Applications
  • Respiratory System
  • Cardiovascular
  • Tumor
  • Other
Companies covered
  • China TCM
  • Yunnan Baiyao
  • Tong Ren Tang
  • Kwangdong
  • Guangzhou Baiyunshan Pharmaceutical
  • Weleda
  • Tsumura
  • Tasly Holding Group
  • Taiji
  • Schwabe
  • Jumpcan Pharmaceutical
  • Huarun 999
  • GW Pharmaceuticals
  • Buchang Pharmaceuticals
  • Bionorica Se

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Botanical and Herbal Drug Market by Type
  3. 1.2.1 Global Botanical and Herbal Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Prescription Drug
  5. 1.2.3 OTC
  6. 1.3 Botanical and Herbal Drug Market by Application
  7. 1.3.1 Global Botanical and Herbal Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Respiratory System
  9. 1.3.3 Cardiovascular
  10. 1.3.4 Tumor
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Botanical and Herbal Drug Market Dynamics
  1. 2.1 Botanical and Herbal Drug Industry Trends
  2. 2.2 Botanical and Herbal Drug Industry Drivers
  3. 2.3 Botanical and Herbal Drug Industry Opportunities and Challenges
  4. 2.4 Botanical and Herbal Drug Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Botanical and Herbal Drug Market Perspective (2021-2032)
  2. 3.2 Global Botanical and Herbal Drug Growth Trends by Region
  3. 3.2.1 Global Botanical and Herbal Drug Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Botanical and Herbal Drug Market Size by Region (2021-2026)
  5. 3.2.3 Global Botanical and Herbal Drug Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Botanical and Herbal Drug Revenue by Players
  2. 4.1.1 Global Botanical and Herbal Drug Revenue by Players (2021-2026)
  3. 4.1.2 Global Botanical and Herbal Drug Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Botanical and Herbal Drug Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Botanical and Herbal Drug Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Botanical and Herbal Drug Key Players Headquarters & Area Served
  7. 4.4 Global Botanical and Herbal Drug Players, Product Type & Application
  8. 4.5 Global Botanical and Herbal Drug Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Botanical and Herbal Drug Market CR5 and HHI
  11. 4.6.3 2025 Botanical and Herbal Drug Tier 1, Tier 2, and Tier 3
5 Botanical and Herbal Drug Market Size by Type
  1. 5.1 Global Botanical and Herbal Drug Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Botanical and Herbal Drug Revenue by Type (2021-2032)
  3. 5.3 Global Botanical and Herbal Drug Revenue Market Share by Type (2021-2032)
6 Botanical and Herbal Drug Market Size by Application
  1. 6.1 Global Botanical and Herbal Drug Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Botanical and Herbal Drug Revenue by Application (2021-2032)
  3. 6.3 Global Botanical and Herbal Drug Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 China TCM
  2. 7.1.1 China TCM Company Information
  3. 7.1.2 China TCM Business Overview
  4. 7.1.3 China TCM Botanical and Herbal Drug Revenue and Gross Margin (2021-2026)
  5. 7.1.4 China TCM Botanical and Herbal Drug Product Portfolio
  6. 7.1.5 China TCM Recent Developments
  7. 7.2 Yunnan Baiyao
  8. 7.2.1 Yunnan Baiyao Company Information
  9. 7.2.2 Yunnan Baiyao Business Overview
  10. 7.2.3 Yunnan Baiyao Botanical and Herbal Drug Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Yunnan Baiyao Botanical and Herbal Drug Product Portfolio
  12. 7.2.5 Yunnan Baiyao Recent Developments
  13. 7.3 Tong Ren Tang
  14. 7.3.1 Tong Ren Tang Company Information
  15. 7.3.2 Tong Ren Tang Business Overview
  16. 7.3.3 Tong Ren Tang Botanical and Herbal Drug Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Tong Ren Tang Botanical and Herbal Drug Product Portfolio
  18. 7.3.5 Tong Ren Tang Recent Developments
  19. 7.4 Kwangdong
  20. 7.4.1 Kwangdong Company Information
  21. 7.4.2 Kwangdong Business Overview
  22. 7.4.3 Kwangdong Botanical and Herbal Drug Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Kwangdong Botanical and Herbal Drug Product Portfolio
  24. 7.4.5 Kwangdong Recent Developments
  25. 7.5 Guangzhou Baiyunshan Pharmaceutical
  26. 7.5.1 Guangzhou Baiyunshan Pharmaceutical Company Information
  27. 7.5.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
  28. 7.5.3 Guangzhou Baiyunshan Pharmaceutical Botanical and Herbal Drug Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Guangzhou Baiyunshan Pharmaceutical Botanical and Herbal Drug Product Portfolio
  30. 7.5.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
  31. 7.6 Weleda
  32. 7.6.1 Weleda Company Information
  33. 7.6.2 Weleda Business Overview
  34. 7.6.3 Weleda Botanical and Herbal Drug Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Weleda Botanical and Herbal Drug Product Portfolio
  36. 7.6.5 Weleda Recent Developments
  37. 7.7 Tsumura
  38. 7.7.1 Tsumura Company Information
  39. 7.7.2 Tsumura Business Overview
  40. 7.7.3 Tsumura Botanical and Herbal Drug Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Tsumura Botanical and Herbal Drug Product Portfolio
  42. 7.7.5 Tsumura Recent Developments
  43. 7.8 Tasly Holding Group
  44. 7.8.1 Tasly Holding Group Company Information
  45. 7.8.2 Tasly Holding Group Business Overview
  46. 7.8.3 Tasly Holding Group Botanical and Herbal Drug Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Tasly Holding Group Botanical and Herbal Drug Product Portfolio
  48. 7.8.5 Tasly Holding Group Recent Developments
  49. 7.9 Taiji
  50. 7.9.1 Taiji Company Information
  51. 7.9.2 Taiji Business Overview
  52. 7.9.3 Taiji Botanical and Herbal Drug Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Taiji Botanical and Herbal Drug Product Portfolio
  54. 7.9.5 Taiji Recent Developments
  55. 7.10 Schwabe
  56. 7.10.1 Schwabe Company Information
  57. 7.10.2 Schwabe Business Overview
  58. 7.10.3 Schwabe Botanical and Herbal Drug Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Schwabe Botanical and Herbal Drug Product Portfolio
  60. 7.10.5 Schwabe Recent Developments
  61. 7.11 Jumpcan Pharmaceutical
  62. 7.11.1 Jumpcan Pharmaceutical Company Information
  63. 7.11.2 Jumpcan Pharmaceutical Business Overview
  64. 7.11.3 Jumpcan Pharmaceutical Botanical and Herbal Drug Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Jumpcan Pharmaceutical Botanical and Herbal Drug Product Portfolio
  66. 7.11.5 Jumpcan Pharmaceutical Recent Developments
  67. 7.12 Huarun 999
  68. 7.12.1 Huarun 999 Company Information
  69. 7.12.2 Huarun 999 Business Overview
  70. 7.12.3 Huarun 999 Botanical and Herbal Drug Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Huarun 999 Botanical and Herbal Drug Product Portfolio
  72. 7.12.5 Huarun 999 Recent Developments
  73. 7.13 GW Pharmaceuticals
  74. 7.13.1 GW Pharmaceuticals Company Information
  75. 7.13.2 GW Pharmaceuticals Business Overview
  76. 7.13.3 GW Pharmaceuticals Botanical and Herbal Drug Revenue and Gross Margin (2021-2026)
  77. 7.13.4 GW Pharmaceuticals Botanical and Herbal Drug Product Portfolio
  78. 7.13.5 GW Pharmaceuticals Recent Developments
  79. 7.14 Buchang Pharmaceuticals
  80. 7.14.1 Buchang Pharmaceuticals Company Information
  81. 7.14.2 Buchang Pharmaceuticals Business Overview
  82. 7.14.3 Buchang Pharmaceuticals Botanical and Herbal Drug Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Buchang Pharmaceuticals Botanical and Herbal Drug Product Portfolio
  84. 7.14.5 Buchang Pharmaceuticals Recent Developments
  85. 7.15 Bionorica Se
  86. 7.15.1 Bionorica Se Company Information
  87. 7.15.2 Bionorica Se Business Overview
  88. 7.15.3 Bionorica Se Botanical and Herbal Drug Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Bionorica Se Botanical and Herbal Drug Product Portfolio
  90. 7.15.5 Bionorica Se Recent Developments
8 North America
  1. 8.1 North America Botanical and Herbal Drug Revenue (2021-2032)
  2. 8.2 North America Botanical and Herbal Drug Revenue by Type (2021-2032)
  3. 8.2.1 North America Botanical and Herbal Drug Revenue by Type (2021-2026)
  4. 8.2.2 North America Botanical and Herbal Drug Revenue by Type (2027-2032)
  5. 8.3 North America Botanical and Herbal Drug Revenue Share by Type (2021-2032)
  6. 8.4 North America Botanical and Herbal Drug Revenue by Application (2021-2032)
  7. 8.4.1 North America Botanical and Herbal Drug Revenue by Application (2021-2026)
  8. 8.4.2 North America Botanical and Herbal Drug Revenue by Application (2027-2032)
  9. 8.5 North America Botanical and Herbal Drug Revenue Share by Application (2021-2032)
  10. 8.6 North America Botanical and Herbal Drug Revenue by Country
  11. 8.6.1 North America Botanical and Herbal Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Botanical and Herbal Drug Revenue by Country (2021-2026)
  13. 8.6.3 North America Botanical and Herbal Drug Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Botanical and Herbal Drug Revenue (2021-2032)
  2. 9.2 Europe Botanical and Herbal Drug Revenue by Type (2021-2032)
  3. 9.2.1 Europe Botanical and Herbal Drug Revenue by Type (2021-2026)
  4. 9.2.2 Europe Botanical and Herbal Drug Revenue by Type (2027-2032)
  5. 9.3 Europe Botanical and Herbal Drug Revenue Share by Type (2021-2032)
  6. 9.4 Europe Botanical and Herbal Drug Revenue by Application (2021-2032)
  7. 9.4.1 Europe Botanical and Herbal Drug Revenue by Application (2021-2026)
  8. 9.4.2 Europe Botanical and Herbal Drug Revenue by Application (2027-2032)
  9. 9.5 Europe Botanical and Herbal Drug Revenue Share by Application (2021-2032)
  10. 9.6 Europe Botanical and Herbal Drug Revenue by Country
  11. 9.6.1 Europe Botanical and Herbal Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Botanical and Herbal Drug Revenue by Country (2021-2026)
  13. 9.6.3 Europe Botanical and Herbal Drug Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Botanical and Herbal Drug Revenue (2021-2032)
  2. 10.2 China Botanical and Herbal Drug Revenue by Type (2021-2032)
  3. 10.2.1 China Botanical and Herbal Drug Revenue by Type (2021-2026)
  4. 10.2.2 China Botanical and Herbal Drug Revenue by Type (2027-2032)
  5. 10.3 China Botanical and Herbal Drug Revenue Share by Type (2021-2032)
  6. 10.4 China Botanical and Herbal Drug Revenue by Application (2021-2032)
  7. 10.4.1 China Botanical and Herbal Drug Revenue by Application (2021-2026)
  8. 10.4.2 China Botanical and Herbal Drug Revenue by Application (2027-2032)
  9. 10.5 China Botanical and Herbal Drug Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Botanical and Herbal Drug Revenue (2021-2032)
  2. 11.2 Asia Botanical and Herbal Drug Revenue by Type (2021-2032)
  3. 11.2.1 Asia Botanical and Herbal Drug Revenue by Type (2021-2026)
  4. 11.2.2 Asia Botanical and Herbal Drug Revenue by Type (2027-2032)
  5. 11.3 Asia Botanical and Herbal Drug Revenue Share by Type (2021-2032)
  6. 11.4 Asia Botanical and Herbal Drug Revenue by Application (2021-2032)
  7. 11.4.1 Asia Botanical and Herbal Drug Revenue by Application (2021-2026)
  8. 11.4.2 Asia Botanical and Herbal Drug Revenue by Application (2027-2032)
  9. 11.5 Asia Botanical and Herbal Drug Revenue Share by Application (2021-2032)
  10. 11.6 Asia Botanical and Herbal Drug Revenue by Country
  11. 11.6.1 Asia Botanical and Herbal Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Botanical and Herbal Drug Revenue by Country (2021-2026)
  13. 11.6.3 Asia Botanical and Herbal Drug Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Botanical and Herbal Drug Revenue (2021-2032)
  2. 12.2 SAMEA Botanical and Herbal Drug Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Botanical and Herbal Drug Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Botanical and Herbal Drug Revenue by Type (2027-2032)
  5. 12.3 SAMEA Botanical and Herbal Drug Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Botanical and Herbal Drug Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Botanical and Herbal Drug Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Botanical and Herbal Drug Revenue by Application (2027-2032)
  9. 12.5 SAMEA Botanical and Herbal Drug Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Botanical and Herbal Drug Revenue by Country
  11. 12.6.1 SAMEA Botanical and Herbal Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Botanical and Herbal Drug Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Botanical and Herbal Drug Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst